Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Culture counts--sustainable inpatient computerized surveillance across Duke University Health System.

Cozart H, Horvath MM, Long A, Whitehurst J, Eckstrand J, Ferranti J.

Qual Manag Health Care. 2010 Oct-Dec;19(4):282-91. doi: 10.1097/QMH.0b013e3181fa0680.

PMID:
20924248
2.

Tailoring adverse drug event surveillance to the paediatric inpatient.

Long AL, Horvath MM, Cozart H, Eckstrand J, Whitehurst J, Ferranti J.

Qual Saf Health Care. 2010 Oct;19(5):e40. doi: 10.1136/qshc.2009.032680. Epub 2010 May 28.

3.

Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study.

Long AL, Bendz L, Horvath MM, Cozart H, Eckstrand J, Whitehurst J, Ferranti J.

Thromb J. 2010 Feb 18;8:5. doi: 10.1186/1477-9560-8-5.

4.

Computerized surveillance of opioid-related adverse drug events in perioperative care: a cross-sectional study.

Eckstrand JA, Habib AS, Williamson A, Horvath MM, Gattis KG, Cozart H, Ferranti J.

Patient Saf Surg. 2009 Aug 11;3(1):18. doi: 10.1186/1754-9493-3-18.

5.

Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.

Ferranti J, Horvath MM, Cozart H, Whitehurst J, Eckstrand J.

Pediatrics. 2008 May;121(5):e1201-7. doi: 10.1542/peds.2007-2609.

PMID:
18450863

Supplemental Content

Loading ...
Support Center